Terms: = Pancreatic cancer AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287 AND Prognosis
3 results:
1. Evaluation of miR-429 as a novel serum biomarker for pancreatic ductal adenocarcinoma and analysis its tumor suppressor function and target genes.
Huang WT; Lin TS; Wu JY; Hong JM; Chen YL; Qiu FN
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4638-4653. PubMed ID: 35856354
[TBL] [Abstract] [Full Text] [Related]
2. Controversial benefit of 5-fluorouracil/leucovorin-based adjuvant chemotherapy for ampullary cancer: a propensity score-matched analysis.
Kang J; Lee W; Shin J; Park Y; Kwon JW; Jun E; Song KB; Lee JH; Hwang DW; Park SY; Kim SC
Langenbecks Arch Surg; 2022 May; 407(3):1091-1097. PubMed ID: 35013798
[TBL] [Abstract] [Full Text] [Related]
3. Leptin-Notch signaling axis is involved in pancreatic cancer progression.
Harbuzariu A; Rampoldi A; Daley-Brown DS; Candelaria P; Harmon TL; Lipsey CC; Beech DJ; Quarshie A; Ilies GO; Gonzalez-Perez RR
Oncotarget; 2017 Jan; 8(5):7740-7752. PubMed ID: 27999190
[TBL] [Abstract] [Full Text] [Related]
